From ECCMID: New Anti-Viral and Bacterial Drugs of Interest From ECCMID: New Anti-Viral and Bacterial Drugs of Interest

Infectious disease expert Dr Paul Auwaerter discusses news from ECCMID, including data on invasive group A streptococcus infections, and the new drugs ensitrelvir, gepotidacin, and sulbactam-durlobactam.Medscape Infectious Diseases
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases Commentary Source Type: news